Skip to main content

Table 1 Costs, in the 1st and 2nd year and their sum after the initial primary care consultation, of use of medications and of subsequent physician visits and the average number (n) of courses of medication, further visits and tests experienced by a patient in each diagnostic category

From: Health-care cost reduction resulting from primary-care allergy testing in children in Italy

Cost items

Cost (€) year

Mean number of episodes in categories a1 to a12

 

1 st

2 nd

sum

a1

a2

a3

a4

a5

a6

a7

a8

a9

a10

a11

a12

Initial allergy test

12

12

24

0

0

0

0

0

0

1(0)e

1(0)

1(0)

1(0)

1(0)

1(0)

Subsequent sIgE tests

8.8

8.5

17.3

0

0

0

0

0

0

10(0)

10(0)

10(0)

0(0)

0(0)

0(0)

Antihistamine use

182a

177

359

0.56

0.44

0.60

0.43

0.43

0.19

0

0.62

0.50

0

0.20

0.09

Corticosteroids use

730b

709

1439

0.44

0.38

0.40

0.48

0.37

0.10

0

0.23

0.25

0.67

0

0.11

Bronchodilators use

64c

62

126

0.11

0.28

0.40

0.33

0.31

0.05

0

0.10

0.25

0

0.10

0.04

Visit Primary care

65

63

128

0.56

0.63

0.60

0.52

0.52

0.29

0

0.60

1

0.33

0.20

0.38

Visit to allergist

65

63

128

0.11

0.24

0

0

0.17

0.05

0

0.32

0.50

0

0.10

0.16

  1. a Based on 1 tablet ceterizin per day for 1 year
  2. b Based on fluticason, 125-250 mg, 4 puffs/day
  3. c Based on salbutamol and fenoterol, 100 mg, 4 puffs/day
  4. dCosts in 2ndyear were discounted to correspond to 1st year (rate:3%)
  5. eNo tests were performed during 2nd year